Recent support of FDA on Avastin biosimilar opens up hope for the Cancer Patients. Biosimilars are large, structurally complex molecules that are intended to be highly similar to, and treat the same condition(s) as, an existing licensed or approved (reference) biologic, with no clinically meaningful differences in purity, potency and safety. Bevacizumab (Avastin) is a […]

The post Will Avastin Biosimilars make their own way soon? A hope for cancer patients appeared first on Innoplexus.